US 7135490
Method for the treatment of glomerulonephritis
granted A61KA61K31/415A61K31/4184
Quick answer
US patent 7135490 (Method for the treatment of glomerulonephritis) held by Takeda Pharmaceutical Company Limited expires Mon Nov 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Nov 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61K, A61K31/415, A61K31/4184, A61K31/4245, A61P